Delivery Order SPE2DB22D3102-SPE2DB24FL2QL
Award Date
8/21/24
Potential Completion Date
8/22/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.97 firm fixed-price delivery order contract is for the supply of 4564885017 Methylergonovine 0.2 mg Tablet Unit Dose 20s medication. The contract has a completion date of June 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,347.93 firm fixed-price delivery order is for the supply of 4565150115 - Methylergonovine 0.2 mg Tablet 12s, with a completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,495.72 firm fixed-price delivery order is for the supply of 4562473934 ! METHYLERGONOVINE 0.2 MG TABLET 28S, with a completion date of October 16, 2023. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,846.48 Firm Fixed Price Delivery Order is for the supply of 4,565,116,351 methylergonovine 0.2 mg tablets. The contract has an ultimate completion date of July 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and other federal healthcare programs....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,421,593 units of the pharmaceutical product Methylergonovine 0.2 mg Tablet. The $1,087.01 firm fixed-price contract has an ultimate completion date of March 3, 2025. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, valued at $2,393.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567064635 - Methylergonovine 0.2 mg/ml vials, with a final completion date of January 29, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,147.50 firm fixed-price delivery order is for the supply of METHYLERGONOVINE 0.2 MG/ML VLML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2022 and was awarded on September 29, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DX15D3013|SPE2DX24FH2H7, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $8,464.00 firm fixed-price delivery order is for the supply of 4563556004 - Methylergonovine 0.2 mg Tablets, with a completion date of February 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company that provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565325980 methylergonovine 0.2 mg tablets in 28-count packages. The contract has a firm fixed price of $1,164.00 and an ultimate completion date of August 5, 2024. This contract is not set aside for any specific business type. Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies to provide a...
This federal contract award, valued at $6,322.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of 4,563,416,314 units of the drug Methylergonovine 0.2 mg tablets. The contract has an ultimate completion date of January 24, 2024 and is structured as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of...